NCT03574389View on ClinicalTrials.gov

A Study Assessing 13-valent Pneumococcal Conjugate Vaccine in Healthy Chinese Infants and Young Children

PHASE3CompletedINTERVENTIONAL
Enrollment

936

Participants

Timeline

Start Date

June 23, 2018

Primary Completion Date

August 23, 2021

Study Completion Date

October 13, 2023

Conditions
Pneumococcal InfectionsPneumococcal Conjugate Vaccine
Interventions
BIOLOGICAL

13vPnC

suspension in prefilled syringe for intramuscular injection, 0.5 mL, only one dose

BIOLOGICAL

Hib

suspension in prefilled syringe for intramuscular injection, 0.5 mL, only one dose

Trial Locations (2)

223300

Huaiyin District Center for Disease Prevention and Control, Huaian

Unknown

Guanyun County Disease Control and Prevention, Lianyungang

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT03574389 - A Study Assessing 13-valent Pneumococcal Conjugate Vaccine in Healthy Chinese Infants and Young Children | Biotech Hunter | Biotech Hunter